Pregnancy Prevention: Clinical Trials

17 trials for Pregnancy Prevention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 unknown, 1 not yet recruiting. 10 Not applicable, 5 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 7, Unknown 2, Not yet recruiting 1
Phase 25Completed 5
Phase 31Completed 1
Phase 41Completed 1

Follow Pregnancy Prevention: new trials by email Literature Review of Pregnancy Prevention trials Research Report on Pregnancy Prevention

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of a Contraceptive Copper Vaginal Ring
Vaginal Ring - Contraception, Birth Control
Not applicableNot yet recruitingElle, MD Biotechnologies Inc.82026-11-152026-10-19
Phase II Study of Ovulation in Obese Women
Levonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.42023-12-102026-06-30
The Impact of Online Educator Mircoskill Training and Parent Microskill Training on Student Sexual-Health Related Outcomes
SkillTalk - HIV/AIDS Prevention, STI Prevention
Not applicableCompletedAshley Philliber62023-04-152024-10-26
Evaluating the Impact of Online Educator Microskill Training on Educator Knowledge and Skill
SkillTalk - HIV/AIDS Prevention, STI Prevention
Not applicableCompletedPhilliber Research & Evaluation792022-08-092024-11-22
A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females
LSP-5415 - Pregnancy Prevention
Phase 2CompletedLupin Research Inc262022-07-052023-03-09
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.192022-06-282026-09-09
An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study
LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring), NuvaRing Vaginal Ring - Pregnancy Prevention
Phase 2CompletedLupin Research Inc402022-02-242022-07-19
Girl2Girl: A Web-based Trial
Girl2Girl - Pregnancy Prevention
Not applicableUnknownCenter for Innovative Public Health Research5742020-07-072021-03-22
Comparative Study of the Contraceptive Efficacy of the Cupid, Cupid 2 and FC2 Female Condom
FC2 Condom, Cupid Condom, Cupid 2 Condom - Pregnancy Prevention
Not applicableCompletedProf Mags Beksinska4002019-11-272022-01-19
A Functional Performance Study of The Wondaleaf Female Condom
Wondaleaf Female Condom, FC2 Female Condom - HIV Prevention, Pregnancy Prevention
Not applicableCompletedProf Mags Beksinska2202019-03-272019-10-23
Project Legacy Impact Evaluation Study
Project Legacy - Pregnancy Prevention, Sexual Behavior
Not applicableCompletedChildren's Hospital Los Angeles5712017-10-302024-01-03
Healthy Adolescent Transitions (HAT)
Healthy Adolescent Transitions (HAT) program - Pregnancy Prevention, Life Skill Development
Phase 2CompletedJack Stevens3312017-08-142024-03-25
Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program
Future Foundation 2.0 PREIS Program - Teen Pregnancy, Pregnancy in Adolescence
Not applicableUnknownMetis Associates, Inc.7002017-05-112018-11-05
Puerto Rico Cuidalos Parent-adolescent Program
Parental Communication intervention, Health promotion control condition - HIV/AIDS and Infections, Sexually Transmitted Diseases
Not applicableCompletedUniversity of Pennsylvania6602012-09-012019-10-16
Using Social Media to Enhance the Impact of the Teen Outreach Program
Teen Outreach Program with Media Enhancement (TOP4ME) - Pregnancy Prevention
Not applicableCompletedColorado School of Public Health8522011-09-012018-05-17
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
DR-103 - Pregnancy Prevention
Phase 3CompletedTeva Women's Health35972009-10-012013-06-24
Continuous Use of COCs
Oral contraceptives--ethinyl estradiol, levonorgestrel - Pregnancy Prevention
Phase 4CompletedFHI 3603622007-08-012011-10-31

Narrower conditions

Sexually Transmitted Diseases (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Sexual Behavior (2)  ·  Coitus (1)  ·  Contraception Behavior (1)  ·  Infections (1)  ·  Social Stigma (1)

Broader conditions

Communicable Diseases (4)  ·  Genital Diseases (4)  ·  Urogenital Diseases (4)  ·  Disease Attributes (3)  ·  Infections (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Behavior (2)  ·  Blood-Borne Infections (2)  ·  HIV Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Lentivirus Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)

Interventions

Levonorgestrel (3)  ·  Meloxicam (2)  ·  Contraceptive Devices, Female (1)  ·  Ethinyl Estradiol (1)  ·  Ethinyl Estradiol-Norgestrel Combination (1)  ·  HLA-DR103 antigen (1)  ·  NuvaRing (1)  ·  etonogestrel (1)

Sponsors

InnovaGyn, Inc. (2)  ·  Lupin Research Inc (2)  ·  Prof Mags Beksinska (2)  ·  Ashley Philliber (1)  ·  Center for Innovative Public Health Research (1)  ·  Children's Hospital Los Angeles (1)  ·  Colorado School of Public Health (1)  ·  Elle, MD Biotechnologies Inc. (1)  ·  FHI 360 (1)  ·  Jack Stevens (1)  ·  Metis Associates, Inc. (1)  ·  Philliber Research & Evaluation (1)  ·  Teva Women's Health (1)  ·  University of Pennsylvania (1)

Countries

United States (10)  ·  India (2)  ·  South Africa (2)  ·  Dominican Republic (1)  ·  Nicaragua (1)

Top investigators

Mags E Beksinska, PhD (2)  ·  Andrea Lukes, MD (1)  ·  Antonia M Villarruel, PhD, RN (1)  ·  David F. Archer, MD (1)  ·  Jack Stevens, PhD (1)  ·  Kavita Nanda, MD, MHS (1)  ·  Leslie F Clark, PhD, MPH (1)  ·  Nelson Varas-Diaz, PhD (1)  ·  Sukhbir Singh, MD (1)  ·  William L. McPheat, PhD (1)

Results publications

PMID 23114735, PMID 12441312, PMID 15541405, PMID 16009156, PMID 16798842, PMID 16855077, PMID 16980507, PMID 18672111, PMID 18929686, PMID 19933235, PMID 23040128, PMID 24576794, PMID 24785854, PMID 24835831, PMID 25259677, PMID 26025453, PMID 26830816, PMID 36426764, PMID 38429618

NIH funding

R01NR013505 (1), R43HD104508 (1), R43HD107861 (1)